Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-17 Sale |
2025-03-19 4:47 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Director |
284 | $6.95 | $1,974 | 34,193 (Direct) |
View |
| 2024-12-16 Sale |
2024-12-20 4:32 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Director |
415 | $4.4867 | $1,862 | 34,477 (Direct) |
View |
| 2024-09-19 Sale |
2024-09-20 6:01 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Director |
131 | $2.79 | $365 | 34,892 (Direct) |
View |
| 2024-09-16 Sale |
2024-09-18 4:30 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Director |
287 | $2.8 | $804 | 35,023 (Direct) |
View |
| 2024-06-17 Sale |
2024-06-20 8:29 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Director |
414 | $3.4014 | $1,408 | 47,810 (Direct) |
View |
| 2024-03-18 Sale |
2024-03-20 5:36 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Director |
413 | $10.61 | $4,380 | 27,391 (Direct) |
View |
| 2024-02-06 Sale |
2024-02-07 4:00 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Director |
9,204 | $13.7 | $126,095 | 27,804 (Direct) |
View |
| 2024-01-12 Sale |
2024-01-17 4:00 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Director |
9,204 | $10.95 | $100,784 | 37,008 (Direct) |
View |
| 2023-12-18 Sale |
2023-12-20 4:03 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Director |
414 | $7.6683 | $3,175 | 46,212 (Direct) |
View |
| 2023-09-18 Sale |
2023-09-20 4:15 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Director |
408 | $9.8877 | $4,034 | 46,626 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-21 4:24 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Director |
413 | $10.04 | $4,146 | 47,034 (Direct) |
View |
| 2023-03-16 Sale |
2023-03-20 4:59 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Director |
5,318 | $0.40939 | $2,177 | 569,399 (Direct) |
View |
| 2022-12-16 Sale |
2022-12-20 4:09 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Director |
13,837 | $0.3969 | $5,492 | 574,717 (Direct) |
View |
| 2022-09-19 Sale |
2022-09-21 4:06 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Chief Financial Officer |
1,348 | $1.13 | $1,523 | 588,554 (Direct) |
View |
| 2022-06-21 Sale |
2022-06-22 4:05 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Chief Financial Officer |
1,351 | $1.14 | $1,540 | 589,902 (Direct) |
View |
| 2022-05-16 Sale |
2022-05-17 4:05 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Chief Financial Officer |
16,627 | $1.03 | $17,126 | 591,253 (Direct) |
View |
| 2022-03-21 Sale |
2022-03-23 4:01 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Chief Financial Officer |
1,409 | $1.27 | $1,789 | 557,880 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-05 4:02 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Chief Financial Officer |
19,612 | $2.05 | $40,205 | 559,289 (Direct) |
View |
| 2021-12-20 Sale |
2021-12-22 4:01 pm |
Verastem Inc. | VSTM | Gagnon Robert E. Chief Financial Officer |
5,497 | $2.27 | $12,478 | 578,901 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-09-17 Option Award |
2024-09-19 9:31 pm |
N/A 2034-09-17 |
Bone Biologics Corp | BBLG | Gagnon Robert E. Director |
30,713 | $0 | 38,728 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-20 8:29 pm |
N/A 2034-06-18 |
Verastem Inc. | VSTM | Gagnon Robert E. Director |
20,833 | $0 | 47,810 (Direct) |
View |
| 2024-01-08 Option Award |
2024-01-10 5:17 pm |
N/A 2034-01-08 |
Bone Biologics Corp | BBLG | Gagnon Robert E. Director |
17 | $0 | 8,024 (Direct) |
View |
Ownership |
2024-01-10 5:15 pm |
N/A N/A |
Bone Biologics Corp | BBLG | Gagnon Robert E. Director |
0 | $0 | 0 (Direct) |
View |
| 2023-05-15 Option Award |
2023-05-16 4:32 pm |
N/A 2033-05-15 |
Verastem Inc. | VSTM | Gagnon Robert E. Director |
62,500 | $0 | 62,500 (Direct) |
View |
| 2022-12-13 Option Award |
2022-12-15 5:24 pm |
N/A 2032-12-13 |
Verastem Inc. | VSTM | Gagnon Robert E. Director |
153,938 | $0 | 153,938 (Direct) |
View |
Ownership |
2022-12-15 5:22 pm |
N/A N/A |
Verastem Inc. | VSTM | Gagnon Robert E. Director |
0 | $0 | 2,043,830 (Direct) |
View |
| 2022-05-14 Option Award |
2022-05-17 4:05 pm |
N/A N/A |
Verastem Inc. | VSTM | Gagnon Robert E. Chief Financial Officer |
50,000 | $0 | 591,253 (Direct) |
View |
| 2021-12-15 Option Award |
2021-12-17 4:02 pm |
N/A 2031-12-15 |
Verastem Inc. | VSTM | Gagnon Robert E. Chief Financial Officer |
450,000 | $0 | 885,898 (Direct) |
View |
| 2021-08-12 Tax Withholding |
2021-12-17 4:02 pm |
N/A N/A |
Verastem Inc. | VSTM | Gagnon Robert E. Chief Financial Officer |
45,329 | $2.87 | 885,898 (Direct) |
View |
| 2020-12-18 Option Award |
2020-12-22 1:33 pm |
N/A 2030-12-18 |
Verastem Inc. | VSTM | Gagnon Robert E. Chief Financial Officer |
271,701 | $0 | 775,411 (Direct) |
View |
| 2020-08-11 Option Award |
2020-08-13 12:01 pm |
N/A N/A |
Verastem Inc. | VSTM | Gagnon Robert E. Chief Financial Officer |
290,210 | $0 | 503,710 (Direct) |
View |